DiscoverCancer ABCs From Surviving To Thriving - How to Thrive with CancerUnderstanding the Real Survival Advantages Provided By Provenge (Sipuleucel-T) for Men with Metastatic Prostate Cancer
Understanding the Real Survival Advantages Provided By  Provenge (Sipuleucel-T) for Men with Metastatic Prostate Cancer

Understanding the Real Survival Advantages Provided By Provenge (Sipuleucel-T) for Men with Metastatic Prostate Cancer

Update: 2019-09-161
Share

Description

Written Transcript at:
https://www.cancerabcs.org/transcript-provengesurvivaladvantage

Dr. Tim Richardson talks with Joel Nowak talk about the real survival advantages that the immunotherapy known as Provenge (sipuleucel-T) offers to men, especially men who get the therapy while their PSA is low (Schellhammer data) and men with an African-American background.  

Along the way, they also talk about what is immunotherapy, how it works, how Provenge is actually administered, its side effects and who should get the treatment and where in their treatment schedule would it be best to get the treatment.  


Support the show (https://www.cancerabcs.org/new-page-2/)
Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Understanding the Real Survival Advantages Provided By  Provenge (Sipuleucel-T) for Men with Metastatic Prostate Cancer

Understanding the Real Survival Advantages Provided By Provenge (Sipuleucel-T) for Men with Metastatic Prostate Cancer

Dr. Tim Richardson, MD from Wichita Urology and Joel T Nowak from Cancer ABCs